Show filters
Resources type
Filter by Resources type
Pathologies
Filter by Pathologies
Technologies
Filter by Technologies
Instruments
Filter by Instruments
68 result(s) found
Sort by:

Sebia receives U.S. FDA Clearance for the FLC Kappa & Lambda assays

Press Release
Mar. 06, 2024

Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.

Sebia UK Carbon reduction plan – 2022

News
Mar. 01, 2024

Sebia’s commitment to carbon neutrality.

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis

Webinar
Feb. 19, 2024

Educational Workshop with Dr. Barbara De la Salle

HYDRASYS 2 SCAN FOCUSING: Overview

Video
Feb. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Press Release
Dec. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

Dec. 09, 2023 Nov. 11, 2023

Event
San Diego, CA

ASH 2023

Sebia booth: #2455

Learn more

Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum

Webinar
Aug. 31, 2023

Educational Webinar with Dr. Matthias Orth from University of Heidelberg at University Hospital Mannheim.

Improving the diagnosis of AATD with aid of Serum Protein Electrophoresis

Webinar
Aug. 23, 2023

Educational Workshop with Dr. Ilaria Ferrarotti